RAD18 may function as a predictor of response to preoperative concurrent chemoradiotherapy in patients with locally advanced rectal cancer through caspase‐9‐caspase‐3‐dependent apoptotic pathway

RAD18 may function as a predictor of response to preoperative concurrent chemoradiotherapy in patients with locally advanced rectal cancer through caspase‐9‐caspase‐3‐dependent apoptotic pathway

Abstract Neoadjuvant chemoradiotherapy (nCRT) has been widely applied to improve the local control rate and survival rate in patients with locally advanced rectal cancer (LARC), yet only part of LARC patients would benefit from nCRT. Therefore, it is imperative to predict the therapeutic outcome of...

Full description

Bibliographic Details
Main Authors:	Xueqi Yan, Jie Chen, You Meng, Chao He, Shitao Zou, Peng Li, Ming Chen, Jinchang Wu, Wei‐Qun Ding, Jundong Zhou
Format:	Article
Language:	English
Published:	Wiley 2019-06-01
Series:	Cancer Medicine
Subjects:	apoptosis locally advanced rectal cancer neoadjuvant chemoradiotherapy RAD18
Online Access:	https://doi.org/10.1002/cam4.2203

Similar Items

2-CONSERVATIVE TREATMENT OF RECTAL ADENOCARCINOMA AFTER NEOADJUVANT CHEMORADIOTHERAPY, IS IT ACCEPTABLE?
by: Majeed H Alwan
Published: (2009-06-01)

Neoadjuvant chemoradiotherapy in combined treatment of patients with rectal cancer
by: N. A. Maistrenko, et al.
Published: (2017-08-01)

Efficacy of modified neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A single institution experience in Taiwan
by: Yi-Ying Wu, et al.
Published: (2014-01-01)

Transcatheter rectal arterial chemoembolization with oxaliplatin plus S-1 concurrent chemoradiotherapy can improve the pathological remission rate in locally advanced rectal cancer: a comparative study
by: Bo Yang, et al.
Published: (2020-05-01)

Nomogram Predicting Overall Survival of Resected Locally Advanced Rectal Cancer Patients with Neoadjuvant Chemoradiotherapy
by: Song J, et al.
Published: (2020-08-01)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
by: Huaqin Lin, et al.
Published: (2021-05-01)

Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
by: Molinari Chiara, et al.
Published: (2011-11-01)

Construction of the Prediction Model for Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy Based on Pretreatment Tumor-Infiltrating Macrophage-Associated Biomarkers
by: Liu X, et al.
Published: (2021-04-01)

Induction chemotherapy, chemoradiotherapy and consolidation chemotherapy in preoperative treatment of rectal cancer - long-term results of phase II OIGIT-01 Trial
by: Golo Danijela, et al.
Published: (2018-09-01)

Prognostic Impact of Pretreatment Elevated and Normalized Carcinoembryonic Antigen Levels After Neoadjuvant Chemoradiotherapy in Resected Locally Advanced Rectal Cancer Patients
by: Song J, et al.
Published: (2021-05-01)

Surgical treatment following neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Ming‐Yii Huang, et al.
Published: (2020-03-01)

Is long interval from neoadjuvant chemoradiotherapy to surgery optimal for rectal cancer in the era of intensity-modulated radiotherapy?: a prospective observational study
by: Chang H, et al.
Published: (2018-09-01)

Watch and wait approach in rectal cancer treatment
by: D. Penchev, et al.
Published: (2016-01-01)

Prognostic Value of the FOXK Family Expression in Patients with Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy
by: Zhang Y, et al.
Published: (2020-09-01)

Accuracy of high-resolution rectal magnetic resonance imaging re-staging with histopathology in locally advanced rectal cancer after neoadjuvant chemoradiotherapy
by: Supparerk Laohawiriyakamol, et al.
Published: (2021-01-01)

Predictive value of carcinoembryonic antigen and carbohydrate antigen 19-9 related to downstaging to stage 0–I after neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Song JY, et al.
Published: (2018-08-01)

The Gut Microbiome Is Associated With Therapeutic Responses and Toxicities of Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients—A Pilot Study
by: Wei Shi, et al.
Published: (2020-12-01)

A Case with Rectal Cancer Relapses After Clinical Complete Remission Following Neoadjuvant Chemoradiotherapy
by: Zhang PB, et al.
Published: (2019-12-01)

Poor prognostic and staging value of tumor deposit in locally advanced rectal cancer with neoadjuvant chemoradiotherapy
by: Yaqi Wang, et al.
Published: (2019-04-01)

Complete histopathological regression in rectal cancer after neoadjuvant chemoradiotherapy and sphincter preserving surgical treatment
by: Petrović Tomislav, et al.
Published: (2018-01-01)

A novel LARCassigner3 classification predicts outcomes in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy: a retrospective training and validation analysis
by: Zhang J, et al.
Published: (2019-05-01)

Phase II randomized trial of capecitabine with bevacizumab and external beam radiation therapy as preoperative treatment for patients with resectable locally advanced rectal adenocarcinoma: long term results
by: Ramón Salazar, et al.
Published: (2020-11-01)

Preoperative chemoradiotherapy for locally advanced gastric cancer
by: Pepek Joseph M, et al.
Published: (2013-01-01)

Pre-Existing Tumoral B Cell Infiltration and Impaired Genome Maintenance Correlate with Response to Chemoradiotherapy in Locally Advanced Rectal Cancer
by: Juan M. Sendoya, et al.
Published: (2020-08-01)

Long-term outcomes of neoadjuvant-synchronous S-1 plus radiotherapy for locally advanced rectal cancer: a multi-institutional prospective phase II study
by: Takahiro Hiratsuka, et al.
Published: (2018-10-01)

Long-course neoadjuvant chemoradiotherapy with versus without a concomitant boost in locally advanced rectal cancer: a randomized, multicenter, phase II trial (FDRT-002)
by: Jingwen Wang, et al.
Published: (2019-11-01)

Impact of Tumor Regression Grade as a Major Prognostic Factor in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Proposal for a Modified Staging System
by: Changhoon Song, et al.
Published: (2018-09-01)

Adding Three Cycles of CAPOX after Neoadjuvant Chemoradiotherapy Increases the Rates of Complete Response for Locally Advanced Rectal Cancer
by: Zhiwei Zhai, et al.
Published: (2021-01-01)

Predictors and Risk Factors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Population-Based Analysis
by: Yinuo Tan, et al.
Published: (2019-06-01)

Addition of platinum derivatives to neoadjuvant single-agent fluoropyrimidine chemoradiotherapy in patients with stage II/III rectal cancer: protocol for a systematic review and meta-analysis (PROSPERO CRD42017073064)
by: Felix J. Hüttner, et al.
Published: (2018-01-01)

Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis
by: Francesca De Felice, et al.
Published: (2017-05-01)

Role of adjuvant chemotherapy in patients with rectal cancer after preoperative chemoradiotherapy: results of a retrospective study
by: M. Yu. Fedyanin, et al.
Published: (2018-07-01)

Alpha-fetoprotein-producing rectal cancer successfully responded to preoperative chemoradiotherapy: case report
by: Yuki Nakamura, et al.
Published: (2018-09-01)

Oral fluorpyrimidines in preoperative chemoradiotherapy for operable rectal cancer
by: Yu. A. Barsukov, et al.
Published: (2016-01-01)

The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
by: J. Martinez-Useros, et al.
Published: (2018-02-01)

PCSK1 Overexpression in Rectal Cancer Correlates with Poor Response to Preoperative Chemoradiotherapy and Prognosis
by: Chou CL, et al.
Published: (2020-04-01)

Genetic prognostic factors for neoadjuvant chemoradiotherapy for colorectal cancer
by: V. A. Grigorenko, et al.
Published: (2021-07-01)

Development of a Joint Prediction Model Based on Both the Radiomics and Clinical Factors for Predicting the Tumor Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer
by: Liu Y, et al.
Published: (2021-04-01)

Delta-radiomics signature predicts treatment outcomes after preoperative chemoradiotherapy and surgery in rectal cancer
by: Seung Hyuck Jeon, et al.
Published: (2019-03-01)

Therapeutic effects of oxaliplatin-based neoadjuvant chemotherapy and chemoradiotherapy in patients with locally advanced rectal cancer: a single-center, retrospective cohort study
by: Takashi Okuyama, et al.
Published: (2018-06-01)

Cannot write session to /tmp/vufind_sessions/sess_tv5c8eghmth05nopjuqlk57lp6